Specifically, three spots, two of which related to Alpha-1-microglobulin (AMBP1 and AMBP2), and one identified as Ganglioside GM2 activator (SAP3) were increased in PCa (Figure 2a) compared to BPH (Figure 2b). This evidence concerns the gene GM2A and benign prostatic hyperplasia.